FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3086914752> ?p ?o ?g. }

• W3086914752 abstract "Background: Chronic lower respiratory tract disease has been the seventh most common cause of death in Taiwan for decades. Previous studies have revealed relationships between the stages of COPD and medical utilization and mortality. However, such research in Taiwan is lacking. Therefore, we investigated the association between the Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages of COPD versions 2007 and 2011 and medical utilization and mortality among patients with COPD to compare the effectiveness of these two versions. Methods: This retrospective study used the clinical database of a medical center in central Taiwan from 2011 to 2017. A total of 613 patients with COPD were identified. Independent variables comprised the 2007 and 2011 versions of the GOLD stages of COPD, demographic characteristics, health status, and physician seniority. Dependent variables included total medical expenses, average duration of hospitalization, and mortality. Statistical methods included binomial logistic regression and the general linear model (GLM). Results: The total medical costs during the observation period for patients with COPD averaged NT$292,455.60. The average duration of hospitalization was 9.7 days. The mortality rate was 9.6%. The adjusted logistic regression analysis indicated that compared with patients with Grade 1 disease as per the 2007 version, patients in 2007 Grade 4 had significantly higher odds of death (OR = 4.07, P = .02). The adjusted GLM analysis revealed that patients in 2011 Group D had a significantly longer duration of hospitalization than those in 2011 Group A version (P = .04). Regarding the total medical costs and accuracy of mortality prediction, no differences were found between the 2007 and 2011 versions. Complications were significantly associated with the total medical utilization and average duration of hospitalization. Conclusions: Higher 2011 GOLD stages of COPD were associated with an increased average duration of hospitalization, whereas higher 2007 GOLD stages of COPD were associated with an increased risk of mortality. This study suggests that both versions of GOLD should be used together in the classification of patients with COPD to help clinicians better evaluate their prognosis, such as mortality and treatment. The findings serve a reference for medical institutions to prioritize high-risk patients with COPD and allocate resources appropriately for preventive interventions." @default.
• W3086914752 created "2020-09-21" @default.
• W3086914752 creator A5003360183 @default.
• W3086914752 creator A5020957673 @default.
• W3086914752 creator A5042866937 @default.
• W3086914752 creator A5071681444 @default.
• W3086914752 date "2020-10-01" @default.
• W3086914752 modified "2023-09-23" @default.
• W3086914752 title "Predicting the Medical Utilization and Mortality of Patients With COPD Using the GOLD Criteria" @default.
• W3086914752 hasPublicationYear "2020" @default.
• W3086914752 type Work @default.
• W3086914752 sameAs 3086914752 @default.
• W3086914752 citedByCount "0" @default.
• W3086914752 crossrefType "journal-article" @default.
• W3086914752 hasAuthorship W3086914752A5003360183 @default.
• W3086914752 hasAuthorship W3086914752A5020957673 @default.
• W3086914752 hasAuthorship W3086914752A5042866937 @default.
• W3086914752 hasAuthorship W3086914752A5071681444 @default.
• W3086914752 hasConcept C126322002 @default.
• W3086914752 hasConcept C151956035 @default.
• W3086914752 hasConcept C156957248 @default.
• W3086914752 hasConcept C167135981 @default.
• W3086914752 hasConcept C179755657 @default.
• W3086914752 hasConcept C194828623 @default.
• W3086914752 hasConcept C2776780178 @default.
• W3086914752 hasConcept C71924100 @default.
• W3086914752 hasConceptScore W3086914752C126322002 @default.
• W3086914752 hasConceptScore W3086914752C151956035 @default.
• W3086914752 hasConceptScore W3086914752C156957248 @default.
• W3086914752 hasConceptScore W3086914752C167135981 @default.
• W3086914752 hasConceptScore W3086914752C179755657 @default.
• W3086914752 hasConceptScore W3086914752C194828623 @default.
• W3086914752 hasConceptScore W3086914752C2776780178 @default.
• W3086914752 hasConceptScore W3086914752C71924100 @default.
• W3086914752 hasOpenAccess W3086914752 @default.
• W3086914752 hasRelatedWork W2048264235 @default.
• W3086914752 hasRelatedWork W2087818841 @default.
• W3086914752 hasRelatedWork W2097104488 @default.
• W3086914752 hasRelatedWork W2134422631 @default.
• W3086914752 hasRelatedWork W2155971227 @default.
• W3086914752 hasRelatedWork W2409133069 @default.
• W3086914752 hasRelatedWork W2550252077 @default.
• W3086914752 hasRelatedWork W2624167443 @default.
• W3086914752 hasRelatedWork W2804671783 @default.
• W3086914752 hasRelatedWork W2927309782 @default.
• W3086914752 hasRelatedWork W2991588456 @default.
• W3086914752 hasRelatedWork W3023260570 @default.
• W3086914752 hasRelatedWork W3034963284 @default.
• W3086914752 hasRelatedWork W3084813425 @default.
• W3086914752 hasRelatedWork W3111205948 @default.
• W3086914752 hasRelatedWork W3126005952 @default.
• W3086914752 hasRelatedWork W3129085694 @default.
• W3086914752 hasRelatedWork W3134668688 @default.
• W3086914752 hasRelatedWork W3191788287 @default.
• W3086914752 hasRelatedWork W3033585647 @default.
• W3086914752 hasVolume "65" @default.
• W3086914752 isParatext "false" @default.
• W3086914752 isRetracted "false" @default.
• W3086914752 magId "3086914752" @default.
• W3086914752 workType "article" @default.